Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-positive Breast Cancer × Fluorodeoxyglucose F18 × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Oropharyngeal Neoplasms 2 Anus Neoplasms 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hodgkin Disease 1 HIV Infections 1 Ependymoma 1 Chordoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pertuzumab 2 Trastuzumab 2 tucatinib 1 pyrotinib 1 Paclitaxel 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡